Federal prosecutors on Tuesday charged former hedge fund manager Mathew Martoma with securities fraud for his alleged role in a highly lucrative insider trading case. Martoma allegedly made illegal use of information regarding the clinical trials for a druge designed to treat Alzheimer’s.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=163101